| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/09/2004 | EP1425256A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions |
| 06/09/2004 | EP1425068A1 Systemical administration of some oxazolidinones, e.g. linezolid, for the treatment of ocular infections |
| 06/09/2004 | EP1425042A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 06/09/2004 | EP1425040A2 In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles |
| 06/09/2004 | EP1425036A2 Virus coat protein/receptor chimeras and methods of use |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | EP1425029A1 Peptidomimetics of biologically active metallopeptides |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1425022A1 Mutagenic nucleoside analogs for the treatment of viral disease |
| 06/09/2004 | EP1425020A1 Methods and compositions for treating apoptosis associated disorders |
| 06/09/2004 | EP1425009A2 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424994A1 Preparation of sustained release pharmaceutical composition |
| 06/09/2004 | EP1424971A1 Eustachian tube stent |
| 06/09/2004 | EP1424957A2 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/09/2004 | EP1424896A1 Method for expression of small rna molecules within a cell |
| 06/09/2004 | EP1424895A2 Method for expression of small antiviral rna molecules within a cell |
| 06/09/2004 | EP1286998B1 Oxazolidinone derivatives with antibiotic activity |
| 06/09/2004 | EP1246824B1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 06/09/2004 | EP1198237B1 Herbal compositions for itchy or infected skin |
| 06/09/2004 | EP1043978B1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | DE10320633A1 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von lebenden Zellen, die einem Reiz ausgesetzt wurden, und lebenden Zellen, die nicht diesem Reiz ausgesetzt wurden A method of identifying a possible modification of at least one biological parameter using living cells that were exposed to a stimulus, and living cells that were not exposed to this stimulus |
| 06/09/2004 | CN1503843A Vaccination against host cell-associated herpesviruses |
| 06/09/2004 | CN1503816A Agent for the prevention and treatment of sexually transmitted diseases-1 |
| 06/09/2004 | CN1503804A Process for preparing 4''-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives |
| 06/09/2004 | CN1503802A Sulfate of cephem compound |
| 06/09/2004 | CN1503796A Polymorphic and other crystalling forms of cis-ftc |
| 06/09/2004 | CN1503795A Water-soluble triazole fungicide |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503675A Telithromycin suspension with a masked taste |
| 06/09/2004 | CN1503673A antiinflammation agents |
| 06/09/2004 | CN1502629A Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/09/2004 | CN1502621A Crystalline n-acetyl neuraminic acid derivatives pharmaceutical compns contg. Them |
| 06/09/2004 | CN1502617A Aromatic amides, preparation method and application as medicines |
| 06/09/2004 | CN1502613A Polymorph of a pharmaceutical and prepation |
| 06/09/2004 | CN1502367A Immunoprophyaxis nose drops and preparation process thereof |
| 06/09/2004 | CN1502365A Sesame flower extract, preparation method and use thereof |
| 06/09/2004 | CN1502358A Use of crataegus pit extract in preparation of medicine for treating gastropathy |
| 06/09/2004 | CN1502357A Use of crataegus pit extract in preparation of medicine for treating mycosis |
| 06/09/2004 | CN1502354A Medicinal composition for preventing mycotic infection of AIDS patient and use thereof |
| 06/09/2004 | CN1502346A Application of Psoralca corylifolia in anti-infection of helicobacter pyloric and treating relative diseases |
| 06/09/2004 | CN1502339A Rareearth beteropoly acid salt (blue) group anti-AIDS medicine and preparation process thereof |
| 06/09/2004 | CN1502336A Application of Astragalosides in preparation of medicine for treating viral myocarditis |
| 06/09/2004 | CN1502335A Application of Netilmicin sulfate in preparation of eye drops |
| 06/09/2004 | CN1502334A Medicinal composition containing Adefovirdipivoxil |
| 06/09/2004 | CN1152957C Human 6-phosphoglucosamine isomerase, its code sequence and application |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/09/2004 | CN1152864C Phenylphenanthridines with PDE-IV inhibiting activity |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152715C Vaccine composition containing polyribosylribitol phosphate and method for making same |
| 06/09/2004 | CN1152702C Chinese mecdicine for treating bone tuberculosis, osteomyelitis phlebitis and organism ulceration |
| 06/09/2004 | CN1152697C Oral cavity bacteriostatic composition containing extract of Chinese herb lotus leaf |
| 06/09/2004 | CN1152693C Adhesion inhibiting composition |
| 06/09/2004 | CN1152691C Use of chemically-stabilized chloride solution for inhibiting antigen-specific immune response |
| 06/09/2004 | CN1152681C 8a-azalides as veterinary antimicrobial agents for animals |
| 06/09/2004 | CN1152678C Pharmaceutical composition comprising lactobacillus plantarum and arginine |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747149 Glucamine salts for treating hepatitis virus infections |
| 06/08/2004 | US6747144 Collections of compounds |
| 06/08/2004 | US6747136 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
| 06/08/2004 | US6747132 Methods for the synthesis of a modified hemoglobin solution |
| 06/08/2004 | US6747056 K99-5041 substance and production thereof |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747028 1,2-substituted benzimidazoles having antiviral activity |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |
| 06/08/2004 | US6747014 For therapy of inflammatory bowel disorder |
| 06/08/2004 | US6747007 Cationic, polyphemusin-like peptides |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/08/2004 | CA2079692C Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 06/03/2004 | WO2004046368A1 Novel antibiotic muraminomicin |
| 06/03/2004 | WO2004046196A2 Compositions and methods for treating bacterial infections with protein-dalbavancin complexes |
| 06/03/2004 | WO2004046176A1 Vaccine against hcv |
| 06/03/2004 | WO2004046175A1 Vaccine |
| 06/03/2004 | WO2004046161A1 Novel 2’,5’-oligoadenylic acid analogues |
| 06/03/2004 | WO2004046159A1 Antiviral nucleoside derivatives |
| 06/03/2004 | WO2004046153A1 Prodrug esters of ceftriaxone |
| 06/03/2004 | WO2004046143A1 Substituted indolepyridinium as anti-infective compounds |
| 06/03/2004 | WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 06/03/2004 | WO2004046109A2 Ionene oligomers and polymers |
| 06/03/2004 | WO2004046101A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 06/03/2004 | WO2004045637A1 Dalbavancin compositions for treatment of bacterial infections |
| 06/03/2004 | WO2004045636A1 Methods of administering dalbavancin for treatment of bacterial infections |
| 06/03/2004 | WO2004045631A1 The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori |
| 06/03/2004 | WO2004045624A1 Medicinal composition |
| 06/03/2004 | WO2004045600A1 Intermediates for aromatic polyketides as selective anticancer and antiviral agents |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004028562A3 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004009021A3 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/03/2004 | WO2003095493A3 Toxin-related antibodies with antimicrobial and antiviral activity |
| 06/03/2004 | WO2003091275A3 Compositions containing anti-hiv peptides and methods of use |
| 06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |